Skip to content
Portage BioTech, LLC.
Portage BioTech, LLC.Portage BioTech, LLC.
  • about us
  • pipeline
  • our companies
    • iOx Therapeutics
    • Intensity Therapeutics
    • Nekonal Oncology
    • Rift Biotherapeutics
    • Stimunity
    • Saugatuck Therapeutics / Oncomer
    • other companies
  • leadership
  • investors / media
    • investor home
    • stock information
    • company information and policies
    • financial and regulatory reports
    • shareholder circular
    • press releases
  • contact
  • about us
  • pipeline
  • our companies
    • iOx Therapeutics
    • Intensity Therapeutics
    • Nekonal Oncology
    • Rift Biotherapeutics
    • Stimunity
    • Saugatuck Therapeutics / Oncomer
    • other companies
  • leadership
  • investors / media
    • investor home
    • stock information
    • company information and policies
    • financial and regulatory reports
    • shareholder circular
    • press releases
  • contact

financial and regulatory reports

  • Home
  • stock information
  • company Information and policies
  • financial and regulatory reports
  • shareholder circular
  • press releases

Consolidated Interim Financial Statements For the three months ended June 30, 2020

read more

MANAGEMENT’S DISCUSSION AND ANALYSIS Prepared as of October 15, 2020

read more

Annual MD&A fiscal 2019/2020

read more

Audited Annual Financials fiscal 2019/2020

read more

2020 form 20-F

read more

FORM 51-102F4 BUSINESS ACQUISITION REPORT

read more

Unaudited Consolidated Financials for Three and Nine Months Ended December 31, 2018

read more

MD & A FOR THREE MONTHS ENDED DECEMBER 31, 2018

read more

Financial Statements for the three and six months ended September 30, 2018

read more

MD & A for the three months ended September 30, 2018

read more

Interim Financial Statements for the three months ended June 30, 2018

read more

MD & A for the three months ended June 30, 2018

read more

Audited Consolidated Annual Financials For the Year Ended March 31, 2018

read more

Annual Report in Form F-20 For the Year Ended March 31, 2018

read more

Interim financials for the three and nine months to December 31, 2017

read more

MD & A for the quarter ended December 31, 2017

read more

OSC ORDER FOR EXEMPTIVE RELIEF

read more

6-K Information Statement

read more

Financial Statements for six months ended September 30, 2017

read more

MD & A for the three months ended September 30, 2017

read more

Consolidated Interim Financials for the Three Months Ended June 30, 2017

read more

MD & A for the three months ended June 30, 2017

read more

Annual Financials for the Year Ending in March 31, 2017

read more

Annual F-20 Report for the Year ending in March 31, 2017

read more

Interim Financial Statements Q3 Fiscal 2017

read more

Management’s Discussion and Analysis Q3 Fiscal 2017

read more

Form S-8

read more

Interim Financial Statements Q2 Fiscal 2017

read more

Management’s Discussion and Analysis Q2 Fiscal 2017

read more

Interim Financial Statements Q1 Fiscal 2017

read more

Management’s Discussion and Analysis Q1 Fiscal 2017

read more

Portage Biotech Form 20-F for Fiscal Year 2016

read more

Portage Biotech Consolidated Financial Statements for Fiscal Year 2016

read more

Interim Financial Statement for Q3 Fiscal 2016

read more

Management’s Discussion and Analysis Q3 Fiscal 2016

read more

Portage Biotech 2016 Annual General Meeting Revised Voting Instruction Form

read more

Portage Biotech 2016 Annual General Meeting Mailing Request Form

read more

Portage Biotech 2016 Annual General Meeting Management Information Circular

read more

Portage Biotech 2016 Annual General Meeting Supplement to the Management Information Circular

read more

Interim Financial Statement for Q2 Fiscal 2016

read more

Management’s Discussion and Analysis Q2 Fiscal 2016

read more

Interim Financial Statement for Q1 Fiscal 2016

read more

Management’s Discussion and Analysis Q1 Fiscal 2016

read more

Consolidated Financial Statement for Fiscal 2015

read more

Form 20-F Annual Report for Fiscal Year 2015

read more

Interim Financial Statement for Q3 Fiscal 2015

read more

Management’s Discussion and Analysis Q3 Fiscal 2015

read more

Interim Financial Statement for Q2 Fiscal 2015

read more

Management’s Discussion and Analysis Q2 Fiscal 2015

read more

Interim Financial Statement for Q1 Fiscal 2015

read more

Management’s Discussion and Analysis Q1 Fiscal 2015

read more

Audited Financial Statements for Fiscal 2014

read more

Form 20-F Annual Report for Fiscal Year 2014

read more

Interim Financial Statements Q3 Fiscal 2014

read more

Management’s Discussion and Analysis Q3 Fiscal 2014

read more

Form S-8

read more

Interim Financial Statement for Q2 Fiscal 2014

read more

Management’s Discussion and Analysis Q2 Fiscal 2014

read more

Interim Financial Statements Q1 Fiscal 2014

read more

Management’s Discussion and Analysis Q1 Fiscal 2014

read more

Consolidated Financial Statements for 2012 and 2013

read more

Form 20-F Annual Report for Fiscal Year 2013

read more
Load more
Portage Biotech, Inc.
Portage Biotech Inc.
Craigmuir Chambers, Road Town,
Tortola, British Virgin Islands, VG1110
416.929.1806
ian@portagebiotech.com


Portage Biotech, Inc.

Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top